Seattle institute shares favorable results for malaria vaccine

06/30/2009 | Seattle Times, The

Researchers at Seattle Biomedical Research Institute have successfully engineered the genes of malaria-carrying parasites and used these to create an experimental vaccine that proved 100% effective in tests on rats and mice. The researchers plan to test the vaccine candidate on humans next year.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ